At the TheRaCiL 2026 Annual Meeting in Cologne, Fiona Copeland had the opportunity to represent the Ciliopathy Alliance to listen, learn and contribute as researchers, clinicians and patient representatives explored how early scientific discoveries might eventually lead to clinical studies that genuinely matter to patients.